20:36 , Jul 19, 2019 |  BC Extra  |  Financial News

Big discounts likely as auction looms for Woodford assets

While Neil Woodford’s Woodford Investment Management is expected to go ahead with an auction of its private biotech holdings this month, three healthcare investors told BioCentury it isn’t a sure thing the fund will be...
19:49 , Jun 7, 2019 |  BioCentury  |  Emerging Company Profile

insitro: machine learning with designated data

Just 12 months after announcing the launch of insitro, AI veteran and CEO Daphne Koller has led the drug discovery and machine learning company to a series A round of over $100 million and a...
23:39 , Jun 5, 2019 |  BC Extra  |  Financial News

Woodford suspends trade in flagship fund as woes for U.K. fund manager mount

Woodford Investment Management has been hit by a pair of setbacks this week as the pressure mounts on the high-profile U.K. fund manager to deliver better returns to investors. On Monday, Woodford announced it suspended...
20:49 , May 24, 2019 |  BioCentury  |  Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

It is clear that Europe has hotspots of innovation that are discovering and developing the next wave of new therapeutic modalities. Nearly every category of new modality has a European champion, with clusters forming around...
22:44 , Sep 13, 2018 |  BC Week In Review  |  Company News

AI healthcare companies forming an alliance

Artificial intelligence healthcare companies are forming an alliance to advance and guide the use of AI in healthcare and drug development. The Alliance for Artificial Intelligence in Healthcare (AAIH) will act as the industry's advocate...
22:37 , Sep 12, 2018 |  BC Extra  |  Politics & Policy

AI healthcare companies forming an alliance

Artificial intelligence healthcare companies are forming an alliance to advance and guide the use of AI in healthcare and drug development. The Alliance for Artificial Intelligence in Healthcare (AAIH) will act as the industry's advocate...
22:48 , May 3, 2018 |  BC Extra  |  Company News

Management tracks: Achillion, Sangamo

Rare disease company Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) said CEO Milind Deshpande will step down. He will be succeeded by President and COO Joseph Truitt. Sangamo Therapeutics Inc. (NASDAQ:SGMO) said SVP and CBO Curt Herberts, III...
19:36 , Apr 20, 2018 |  Completed Offerings  |  Completed Offerings

BenevolentAI raises $115M

BenevolentAI (London, U.K.) raised $115 million on April 19 in a financing round that drew participation from 50 new and existing investors, including existing investor Woodford Investment Management. Most of the investors were U.S.-based. BenevolentAI’s...
17:40 , Apr 19, 2018 |  BC Extra  |  Financial News

BenevolentAI raises $115M

BenevolentAI (London, U.K.) raised $115 million in a financing round that drew participation from 50 new and existing investors, including existing investor Woodford Investment Management. Most of the investors were U.S.-based. BenevolentAI’s Judgment Augmented Cognition...
00:38 , Mar 7, 2018 |  BC Innovations  |  Translation in Brief

Arcing toward AI

LifeArc announced in January it is tapping into AI capabilities at the University of Cambridge’s Milner Therapeutics Institute through a partnership aimed at identifying and validating new targets for cancer immunotherapy and respiratory disease early...